Cutaneous ulcers in association with sprue-like enteropathy secondary to Losartan.
Losartan
angiotensin II receptor blocker
chronic diarrhea
sprue‐like enteropathy
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
06
05
2021
revised:
28
06
2021
accepted:
08
07
2021
entrez:
25
8
2021
pubmed:
26
8
2021
medline:
26
8
2021
Statut:
epublish
Résumé
Losartan is an angiotensin II receptor blocker (ARB) which may cause severe sprue-like enteropathy (SLE) with skin manifestation. Clinicians should be informed of this side effect and its reversibility after cessation of the drug.
Identifiants
pubmed: 34430010
doi: 10.1002/ccr3.4645
pii: CCR34645
pmc: PMC8365551
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e04645Informations de copyright
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
World J Gastroenterol. 2013 Oct 28;19(40):6928-30
pubmed: 24187471
Dig Liver Dis. 2018 Jun;50(6):621-624
pubmed: 29625908
Intern Med. 2016;55(24):3675-3678
pubmed: 27980272
Curr Gastroenterol Rep. 2019 Nov 13;21(11):55
pubmed: 31720893
Aliment Pharmacol Ther. 2015 Dec;42(11-12):1303-14
pubmed: 26423313
Clin Case Rep. 2016 Mar 02;4(4):379-82
pubmed: 27099732
J Gastroenterol Hepatol. 2018 Oct;33(10):1691
pubmed: 29968297
J Clin Gastroenterol. 2015 Oct;49(9):794
pubmed: 26166143
Am J Gastroenterol. 2017 Nov;112(11):1754-1755
pubmed: 29109495
Nutrients. 2018 May 12;10(5):
pubmed: 29757210
Gastroenterol Rep (Oxf). 2019 Jun;7(3):162-167
pubmed: 31217979
Eur J Hosp Pharm. 2020 Jan;27(1):49-51
pubmed: 32064089
Cureus. 2019 Dec 17;11(12):e6400
pubmed: 31970030